NCT05805137 (WoundWatch®) is a NA clinical trial of WoundWatch® wound monitoring system in Venous Ulcer, sponsored by CutoSense Oy.

Who is sponsoring NCT05805137?

NCT05805137 is sponsored by CutoSense Oy.

What drugs are being tested in NCT05805137?

Interventions in NCT05805137: WoundWatch® wound monitoring system.

What condition does NCT05805137 study?

NCT05805137 studies Venous Ulcer.

Is NCT05805137 still recruiting?

NCT05805137 is currently recruiting now. Last updated 17 March 2026.

Last reviewed 2026-03-17 · How we verify

NCT05805137: WoundWatch®

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Monitoring of Venous Ulcers Using a Bioimpedance Measurement Based Method and System

Recruiting now NA Last updated 17 March 2026

What this trial tests

NA trial testing WoundWatch® wound monitoring system in Venous Ulcer in 20 participants. Currently enrolling.

Timeline

20 April 2023

Primary endpoint
30 November 2026

31 December 2026

Quick facts

Lead sponsor	CutoSense Oy
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	20
Start date	20 April 2023
Primary completion	30 November 2026
Estimated completion	31 December 2026
Sites	2 locations across Finland, Poland

Drugs / interventions tested

WoundWatch® wound monitoring system

Conditions studied

Venous Ulcer — all drugs for Venous Ulcer →

Sponsor

CutoSense Oy — full company profile →

Who can join

18 and older, any sex, with Venous Ulcer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the functionality of a new type of wound monitoring method and measurement system for monitoring healing of venous ulcers. The system is consisted of a wound dressing with electrodes (eDressing), a bioimpedance measurement device and a mobile phone application.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Bioimpedance Measurement for Monitoring Chronic Wounds: A Systematic Review.
Antoszewska M, Połomska K, Spychalski P, Kekonen A, et al · · 2025 · cited 1× · PMID 40505690 · DOI 10.1111/iwj.70707

Verify or expand the search:

Other recruiting trials for Venous Ulcer

Currently open trials in the same condition.

NCT06031714 — Fetal Cell Receptors Repertoire · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05805137 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by CutoSense Oy
Last refreshed: 17 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05805137.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing